Filing Details

Accession Number:
0001213900-22-027791
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-17 21:51:49
Reporting Period:
2022-05-16
Accepted Time:
2022-05-17 21:51:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1733413 Tff Pharmaceuticals Inc. TFFP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1568678 R. Glenn Mattes 1751 River Run, Suite 400
Fort Worth TX 76107
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-16 16,000 $4.78 36,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,000 Indirect Shares held by spouse
Footnotes
  1. The reported shares were purchased in the open market in multiple transactions at prices ranging from $4.32 to $4.95. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).